In recent years, the field of autism research has witnessed an increasing emphasis on emotional regulation, a critical area of intervention that holds the potential to profoundly impact the quality of life for autistic individuals and their families. Among the emerging therapeutic modalities is the innovative group therapy known as Regulating Together (RT), developed to support school-age autistic youth grappling with emotion dysregulation alongside their caregivers. A newly published study protocol in BMC Psychology outlines a meticulously designed randomized controlled trial (RCT) aiming to rigorously evaluate the efficacy of RT, promising pivotal advancements in both clinical practice and research methodologies related to autism spectrum disorder (ASD).
Emotion dysregulation is a prevalent and often debilitating challenge faced by many autistic youth. It manifests as difficulty in managing emotional responses, heightened sensitivity to environmental stimuli, and difficulties transitioning between activities or states. These emotional disturbances frequently compromise social functioning, academic engagement, and overall well-being, making targeted interventions all the more urgent. The RT program, as introduced by McKinney et al., represents a comprehensive, group-based therapeutic framework designed specifically to address these challenges through structured support mechanisms that engage both the child and their caregivers simultaneously.
At the core of the RT protocol is the recognition that emotion regulation is a learned skill that can be cultivated with appropriate therapeutic guidance. Unlike traditional individual therapy models that may focus solely on the child or the adolescent, RT leverages the dynamic interplay between the youth and their caregivers in a group setting, fostering mutual understanding and shared strategies for managing emotional difficulties. This dyadic approach acknowledges the bidirectional influence emotions have within family systems, aiming to produce sustainable improvements by enhancing communication and emotional attunement.
The methodology of the trial employs a randomized controlled design, widely regarded as the gold standard in clinical research, to ensure the reliability and validity of the findings. Participants—school-age autistic youth diagnosed according to DSM-5 criteria and exhibiting clinically relevant emotion dysregulation—will be randomly assigned to either the RT intervention group or a control group receiving usual care. This design enables researchers to isolate the effects of RT by controlling for confounding variables, which often complicate the interpretation of observational and open-label studies.
A distinctive feature of RT lies in its curriculum, which integrates cognitive-behavioral techniques, mindfulness-based stress reduction, and parent-mediated strategies to build emotion regulation skills. Sessions are structured around developing emotional awareness, recognizing triggers, and implementing coping mechanisms. For example, children are taught to identify physiological signs of escalating emotions and apply self-soothing techniques, whereas caregivers learn to provide supportive responses that reinforce these skills outside of formal therapy sessions. The synergy derived from simultaneous participation aims to create a nurturing environment conducive to practicing and generalizing newly acquired skills in real-world contexts.
Importantly, RT sessions are delivered in carefully facilitated groups, allowing participants to share experiences, normalize emotional struggles, and develop peer support networks. This group setting not only enhances social connectedness but also provides opportunities for social learning, an area where many autistic youth face challenges. Through guided interactions, youth observe and model adaptive emotional responses, while caregivers exchange strategies for managing stress and reinforcing positive behaviors at home.
The trial also includes comprehensive outcome assessments measuring changes in emotion regulation abilities, behavioral problems, mental health symptoms, and family functioning. Both quantitative and qualitative data will be collected at multiple time points, providing a nuanced understanding of the intervention’s impact over time. Advanced psychometric instruments and caregiver-report scales will be complemented by physiological measures such as heart rate variability, which serves as a biomarker for emotional arousal and regulatory capacity. This multimodal approach enhances the scientific rigor by triangulating subjective and objective indicators of emotional health.
From a theoretical perspective, RT is grounded in contemporary models of emotional development and neurodiversity, which emphasize neurobiological differences while affirming the plasticity of emotional processes. The treatment’s conceptual framework draws from the process model of emotion regulation, highlighting the importance of antecedent-focused strategies (e.g., reappraisal) and response-focused strategies (e.g., suppression or expression). By tailoring these strategies to the unique cognitive and sensory profiles of autistic children, RT offers an individualized yet evidence-based pathway toward emotional resilience.
Furthermore, the implications of this research extend beyond clinical efficacy. If successful, RT could inform policy initiatives aimed at integrating caregiver-inclusive mental health interventions within educational and community settings. Given the strain emotion dysregulation exerts on healthcare resources and family dynamics, scalable group therapies like RT could serve as cost-effective alternatives or adjuncts to traditional one-on-one therapy, broadening access especially in underserved populations.
The trial’s protocol also meticulously addresses ethical considerations, ensuring informed consent, participant confidentiality, and accommodation of sensory or communication needs typical among autistic individuals. Regular safety monitoring and adaptive procedures are incorporated, reflecting a commitment to participant welfare and inclusive research practices. Transparency and reproducibility are upheld through preregistration of the trial and open sharing of de-identified data upon publication, aligning with principles of open science.
Technological innovations assist in the delivery and evaluation of the RT program. Telehealth options are incorporated to enhance participation flexibility, particularly relevant in post-pandemic contexts where remote interventions have become indispensable. Digital tools support homework assignments, emotion tracking, and caregiver collaboration, thereby augmenting engagement and data accuracy. The integration of ecology momentary assessment (EMA) methods enables real-time data capture, providing insights into immediate emotional experiences and regulatory efforts beyond the clinical setting.
The anticipated challenges acknowledged by the research team include variability in participant engagement, heterogeneity of autism presentations, and balancing intervention fidelity with individualized adaptations. Addressing these factors systematically will enhance the interpretability and generalizability of the trial outcomes, setting a high standard for future investigations.
As the field eagerly awaits the trial’s results, the publication of this study protocol represents a critical step in advancing evidence-based practices targeting emotion dysregulation among autistic youth. The hope is that Regulating Together will not only alleviate emotional distress but also empower families with the tools necessary for thriving across developmental stages, marking a paradigm shift toward more dynamic, family-centered autism therapies.
The broader scientific community recognizes the urgent need for such interventions given rising prevalence rates of ASD and growing awareness of the associated emotional and behavioral complexities. By leveraging rigorous methodology and innovative therapeutic constructs, the McKinney et al. team’s work is poised to make a transformative contribution to autism care that reverberates well beyond academic circles.
In summary, the outlined RCT protocol for Regulating Together provides a comprehensive, methodologically sound framework for evaluating a novel group therapy designed to attenuate emotion dysregulation in autistic children and their caregivers. Through integrating psychological theory, clinical expertise, and family dynamics, this trial promises to inform future clinical guidelines, enhance therapeutic outcomes, and improve the lived experiences of many affected families. Its careful attention to detail, inclusivity, and scientific rigor embodies the progressive spirit essential for tackling complex neurodevelopmental challenges.
Subject of Research: Emotion dysregulation in school-age autistic youth and their caregivers
Article Title: Study protocol for a randomized controlled trial of Regulating Together (RT), a group therapy for emotion dysregulation in school-age autistic youth and their caregivers
Article References:
McKinney, W.S., Tadevich, L.J., Schmitt, L.M. et al. Study protocol for a randomized controlled trial of Regulating Together (RT), a group therapy for emotion dysregulation in school-age autistic youth and their caregivers. BMC Psychol 13, 436 (2025). https://doi.org/10.1186/s40359-025-02737-6
Image Credits: AI Generated
